Cargando…
3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials
This study evaluated the efficacy and safety of 3% nebulized hypertonic saline (NHS) in infants with acute bronchiolitis (AB). METHODS: We systematically searched the PUBMED, EMBASE, Cochrane Library, China National Knowledge Infrastructure Database, WANFANG, and VIP databases from inception to June...
Autores principales: | Yu, Jin-Feng, Zhang, Yan, Liu, Zhan-Bo, Wang, Jing, Bai, Li-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662888/ https://www.ncbi.nlm.nih.gov/pubmed/36316926 http://dx.doi.org/10.1097/MD.0000000000031270 |
Ejemplares similares
-
Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta‐analysis
por: Pereira, Renan A., et al.
Publicado: (2022) -
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020) -
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
por: Hsieh, Chia-Wen, et al.
Publicado: (2020) -
Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial
por: Flores-González, J. Carlos, et al.
Publicado: (2015) -
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
por: Beal, Gaëlle, et al.
Publicado: (2019)